Company Filing History:
Years Active: 1999-2001
Title: The Innovations of Robert J. Hoenle
Introduction
Robert J. Hoenle is a notable inventor based in Crystal Lake, IL (US). He has made significant contributions to the field of molecular diagnostics, particularly in the detection of oncogenic viruses. With a total of 3 patents, his work has had a profound impact on public health.
Latest Patents
Hoenle's latest patents include innovative nucleic acid primers and probes designed for detecting oncogenic human papillomaviruses (HPV). These probe sequences are specifically useful for identifying HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68. The sequences can be utilized in hybridization assays or amplification-based assays to detect the presence of these oncogenic HPV types in test samples. Additionally, these sequences can be provided as part of a diagnostic kit. Another significant patent involves primer/probe sets for detecting HIV-1 and HIV-2. These sets are designed for use in nucleic acid amplification procedures, including PCR or RT PCR, and can also be packaged in kits with other necessary reagents.
Career Highlights
Hoenle is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on developing advanced diagnostic tools that aid in the detection of critical viral infections.
Collaborations
Throughout his career, Hoenle has collaborated with esteemed colleagues such as Paul E. Kroeger and Klara Abravaya. These collaborations have further enhanced the quality and impact of his inventions.
Conclusion
Robert J. Hoenle's contributions to the field of molecular diagnostics exemplify the importance of innovation in healthcare. His patents not only advance scientific knowledge but also provide essential tools for disease detection and management.